Previous studies established that arachidonic acid is metabolized by the cytochrome P450 (CYP) enzymes of the 4A and 4F families to 20-hydroxyeicosatetraenoic (20-HETE) that regulates renal function and vascular tone. Elevations in the 20-HETE have been reported to increase blood pressure by promoting endothelial dysfunction, vascular inflammation, oxidative stress and endothelial expression of angiotensin-converting enzyme, which increase circulating angiotensin II levels. However, mutations in and that inhibit the formation of 20-HETE have been linked to hypertension in human genetic studies, and a deficiency in 20-HETE promotes sodium retention and hypertension in Dahl salt-sensitive rats. This Perspective focuses on knowledge gaps concerning the pro- versus anti-hypertensive actions of 20-HETE and the GPR75/20-HETE receptor in mediating these effects.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11410503 | PMC |
http://dx.doi.org/10.1161/HYPERTENSIONAHA.124.21718 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!